ClinicalTrials.gg
RecruitingNCT07237139INSPIREUpdated Dec 9, 2025

Pulmonary Volume Changes During Synchonized Noninvasive Positive Pressure Ventilation

An observational study in Infant, Preterm, Respiratory Distress Syndrome (Neonatal) and Chronic Lung Disease of Newborn, sponsored by University of Zurich. Recruiting at 1 site in Switzerland. Open to participants aged Up to 4 Weeks. Per ClinicalTrials.gov, last updated 2025-12-09.

Sponsored by University of Zurich · Observational

How we know

From the registry’s dates

  • Started Nov 2025; still recruiting 1 year later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
27
Ages
Up to 4 Weeks
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 34 studies in Premature Birth with a site in Switzerland — 12 open to participants now, 14 under way, none of them phase 3. Premature Birth · Switzerland.

Planned enrollment
14th of 14
27 · median 168
Started
2025
with 3 others
Observational
14 of 34
6 open now
Primary completion
2026-12
later than 10 of 13 live
Registered
31st of 34
by date
Lead sponsor
7 of 34
University of Zurich

Among the 34 studies in Premature Birth with a site in Switzerland, this one is the 14th largest by planned enrollment of the 14 observational ones that give a count, is one of 4 that started in 2025, is one of 14 observational ones, reaches primary completion later than 10 of the 13 other live ones, and was the 31st registered.

Premature Birth

2,557 studies on the registry are indexed under Premature Birth; 504 are open to participants now.

Browse Premature Birth studies →

Open to participants now

12 of the 34 studies in Premature Birth with a site in Switzerland are open now. Recruiting first, the newest first:

6 more — sign in →

All 12 open studies →

A study can be open while its sites in Switzerland have not opened yet or have stopped. Only those recruiting at a site in Switzerland →

Who these studies take

Of the 318 Premature Birth studies recruiting now, 88 (28%) set no upper age limit and 226 (71%) stop at 75 or younger; 243 take children under 18; 104 take healthy volunteers.

This study: Up to 4 Weeks · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 34 studies in Premature Birth with a site in Switzerland, or all of them as a file.
02

Study summary

Current evidence suggests that noninvasive positive pressure ventilation (NIPPV) is more effective than continuous positive airway pressure (CPAP) in preventing respiratory failure in preterm infants with respiratory distress syndrome (RDS), both as initial and post-extubation support. NIPPV may be delivered in synchronized (sNIPPV) or non-synchronized (nsNIPPV) modes, with sNIPPV offering clear benefits by coordinating support with the infant's own breathing. Recent studies indicate sNIPPV is superior to nsNIPPV in preventing respiratory failure, though the intrapulmonary mechanisms behind this advantage remain unclear. To address this, the present study uses Electrical Impedance Tomography (EIT) to evaluate how lung volume changes during different types of breaths and ventilator inflations - spontaneous breaths, synchronized inflations, non-synchronized inflations, and backup inflations - in preterm infants receiving sNIPPV.

Read the detailed description

Hypothesis:

Synchronized inflations during NIPPV will increase tidal volumes (VT) and lung aeration when compared with non-synchronized inflations. Pressure peaks delivered during expiration (non-synchronized inflations), between spontaneous breaths (backup inflations), or during periods of apnea (backup inflations) will not increase relative VT.

Primary objective:

The primary objective is to assess lung volume changes between spontaneous breaths and synchronized inflations, non-synchronized inflations, and backup inflations using EIT.

Secondary objectives:

The secondary objectives are to assess regional differences in aeration and ventilation among spontaneous breaths, synchronized inflations, non-synchronized inflations, and backup inflations using EIT.

Primary endpoint:

Difference in relative Vt (rel. Delta-Z) between spontaneous breaths and synchronized inflations.

Study procedures:

Study procedures include attaching an EIT belt and a pulse oximeter sensor during the final nursing care session before the study begins. Synchronized NIPPV is provided by EVEneo ventilators, and synchronization will be achieved through an abdominal capsule (Graseby).

  1. Sixty minutes after the beginning of the EIT recording , the noninvasve ventilation mode will be switched to CPAP for 2 minutes. This 2-minute period will be the baseline period during which spontaneous breathing will be assessed.
  2. The NIV mode will then be switched back to sNIPPV. Ventilator settings will be maintained at the same levels used before the start of the study, and adjustments will not be permitted.
  3. Prior to the next nursing care session, a second 2-minute nCPAP period will be introduced and serve as the baseline (together with the 1st CPAP period) .
  4. The EIT recording and SpO2/HR measurements will continue until the next nursing care round, at which point the EIT belt and SpO2 sensor will be removed.
03

Conditions studied

  • Infant, Preterm
  • Respiratory Distress Syndrome (Neonatal)
  • Chronic Lung Disease of Newborn
  • Respiratory Support
  • Synchronized Noninvasive Positive Pressure Ventilation (SNIPPV)
  • Lung Volume

Keywords

  • Synchronized noninvasive positive pressure ventilation (SNIPPV)
  • Lung volume
  • Electrical Impedance Tomography (EIT)
  • infant, preterm
04

Who can participate

Ages eligible
Up to 4 Weeks
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

This study will take place at the Department of Neonatology of the University Hospital Zurich. Preterm infants on a synchronized mode of non-invasive positive pressure ventilation will be screened for eligibility and parents will be approached by the treating physician or a clinician-researcher who is authorized to access the patient's clinical data.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Written by one or both parents or legal guardians
  • Gestational age at birth \< 30 0/7 weeks
  • Infants on sNIPPV respiratory support
  • Below 4 weeks chronological age

Exclusion criteria

Exclusion Criteria:

  • Severe congenital malformation adversely affecting lung aeration or perfusion (e.g., congenital heart defects)
  • Too ill/unstable in the opinion of the treating physician.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
27 participants (estimated)
Patient registry
No

Groups and cohorts

  • Preterm infants with a gestational age < 30 0/7 weeks at birth

    Infants on sNIPPV respiratory support and below 4 weeks chronological age

    Device: Electrical Impedance Tomography (EIT)

Interventions

  • DeviceElectrical Impedance Tomography (EIT)

    Electrical Impedance Tomography and clinical data will be recorded continuously. Corresponding data will be extracted and analyzed at five pre-defined timepoints.

06

What researchers measure

Primary outcomes

  1. Tidal volume (VT)

    Difference in relative VT (rel. ΔZ) between spontaneous breaths and synchronized inflations.

    Time frame: At five pre-defined timepoints from the beginning to the end of the study at 180 minutes.

Secondary outcomes

  1. Global lung impedance

    Difference between end-expiratory lung impedance (EELI) and inspiratory onset lung impedance (SILI) during spontaneous breaths, synchronized inflations, non-synchronized inflations, and back-up inflations.

    Time frame: At five pre-defined timepoints from the beginning to the end of the study at 180 minutes.

  2. Regional tidal volume distribution

    Difference in regional tidal distribution between spontaneous breaths, synchronized inflations, non-synchronized inflations and back-up inflations

    Time frame: At five pre-defined timepoints from the beginning to the end of the study at 180 minutes.

  3. Center of ventilation

    Difference in center of ventilation between spontaneous breaths, synchronized inflations, non-synchronized inflations and back-up inflations

    Time frame: At five pre-defined timepoints from the beginning to the end of the study at 180 minutes.

  4. Silent spaces

    Difference in silent spaces between spontaneous breaths, synchronized inflations, non-synchronized inflations and back-up inflations

    Time frame: At five pre-defined timepoints from the beginning to the end of the study at 180 minutes.

  5. Global inhomogeneity index

    Difference in global inhomogeneity index between spontaneous breaths, synchronized inflations, non-synchronized inflations and back-up inflations. An inhomogeneity index of zero represents a perfectly homogeneous distribution of ventilation.

    Time frame: At five pre-defined timepoints from the beginning to the end of the study at 180 minutes.

  6. Coefficient of variation

    Difference in coefficient of variation (EIT) between spontaneous breaths, synchronized inflations, non-synchronized inflations and back-up inflations

    Time frame: At five pre-defined timepoints from the beginning to the end of the study at 180 minutes.

  7. Inspiratory time

    Difference in inspiratory times between spontaneous breaths, synchronized inflations, non-synchronized inflations and back-up inflations

    Time frame: At five pre-defined timepoints from the beginning to the end of the study at 180 minutes.

  8. Expiratory time

    Difference in expiratory times between spontaneous breaths, synchronized inflations, non-synchronized inflations and back-up inflations

    Time frame: At five pre-defined timepoints from the beginning to the end of the study at 180 minutes.

  9. Lung ultrasound score

    Difference in lung ultrasound score at two pre-defined timepoints. Each lung will be divided into 3 areas. For each lung area, a 0- to 3-point score will be given (total score ranging from 0-18). Higher scores represent greater severity of lung disease.

    Time frame: Immediately before the first infant handling as well as following electrical impedance tomography belt removal.

  10. Heart rate

    Changes of heart rate between five pre-defined time points.

    Time frame: Continuous measurement during the 180-minute recording period.

  11. Peripheral oxygen saturation

    Changes in oxygen saturation between five pre-defined time points.

    Time frame: Continuous measurement during the 180-minute recording period.

  12. Oxygen supplementation

    Changes in FiO2 between five pre-defined time points.

    Time frame: Continuous measurement during the 180-minute recording period.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2025 (actual). Primary completion is estimated for Dec 2026, 13 months after the start.

Of 373 non-industry observational studies under Premature Birth, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 63. This study's planned 13 months is below that.

Counting every sponsor, half of 388 studies reached it within 35 months; a quarter within 19 and three quarters within 61.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 14, 2025
First posted
Nov 19, 2025
StartActual
Nov 17, 2025
Primary completionEst.
Dec 31, 2026
CompletionEst.
Jan 30, 2027
Last update
Dec 9, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 9, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07237139
Collaborators
University Hospital, Zürich
Responsible party
Sponsor
First posted
Nov 19, 2025
Start date
Nov 17, 2025
Primary completion
Dec 31, 2026 (estimated)
Completion
Jan 30, 2027 (estimated)
Last update
Dec 9, 2025

Study contacts

Christoph M Rüegger, MD
Contact
christoph.rueegger@usz.ch
+41432539810
Claudia Knöpfli
Contact
claudia.knoepfli@usz.ch
+41442555340
Vincenzo Cannizzaro, MD
study chair · Newborn Research, Department of Neonatology, University Hospital and University of Zurich, Zurich, Switzerland

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion